PAOLINI, ERIKA
PAOLINI, ERIKA
Dipartimento di Scienze Farmacologiche e Biomolecolari
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution
2022-02-01 M. Longo, E. Paolini, M. Meroni and Paola Dongiovanni
The KLB rs17618244 gene variant is associated with fibrosing MAFLD by promoting hepatic stellate cell activation
2021-03-01 N. Panera, M. Meroni, M. Longo, A. Crudele, L. Valenti, E. Bellacchio, L. Miele, V. D'Oria, E. Paolini, M. Maggioni, A.L. Fracanzani, A. Alisi, P. Dongiovanni
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
2021-01-01 M. Meroni, M. Longo, R. Lombardi, E. Paolini, C. Macchi, A. Corsini, C.R. Sirtori, A.L. Fracanzani, M. Ruscica, P. Dongiovanni
Mitochondrial dynamics and nonalcoholic fatty liver disease (NAFLD): new perspectives for a fairy-tale ending?
2021-04-01 M. Longo, M. Meroni, E. Paolini, C. Macchi, P. Dongiovanni
NAFLD or MAFLD diagnoses and cardiovascular diseases: from epidemiology to drug approaches
2021-07-01 P. Dongiovanni, E. Paolini, A. Corsini, C.R. Sirtori, M. Ruscica
Recreating gut-liver axis during NAFLD onset by using a Caco-2/HepG2 co-culture system
2022-02-22 M. Meroni, E. Paolini, M. Longo, R. Piciotti, G. Tria, S. Fargion, A. Ludovica Fracanzani, P. Dongiovanni
Remodeling of mitochondrial plasticity: The key switch from NAFLD/Nash to HCC
2021-04-17 M. Longo, E. Paolini, M. Meroni, P. Dongiovanni
The rs599839 a>g variant disentangles cardiovascular risk and hepatocellular carcinoma in nafld patients
2021-01-01 M. Meroni, M. Longo, E. Paolini, A. Alisi, L. Miele, E.R. De Caro, G. Pisano, M. Maggioni, G. Soardo, L.V. Valenti, A.L. Fracanzani, P. Dongiovanni
TM6SF2/PNPLA3/MBOAT7 Loss-of-Function Genetic Variants Impact on NAFLD Development and Progression Both in Patients and in In Vitro Models
2022-01-01 M. Longo, M. Meroni, E. Paolini, V. Erconi, F. Carli, F.R. Fortunato, D. Ronchi, R. Piciotti, S. Sabatini, C. Macchi, A. Alisi, L. Miele, G. Soardo, G.P. Comi, L.V.C. Valenti, M. Ruscica, A.L. Fracanzani, A. Gastaldelli, P. Dongiovanni
$\upalpha$-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study [alpha-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study]
2021-09-01 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni
The α-Lipoic Acid Improves Hepatic Metabolic Dysfunctions in Acute Intermittent Porphyria: A Proof-of-Concept Study
2021-08-04 M. Longo, E. Paolini, M. Meroni, L. Duca, I. Motta, A.L. Fracanzani, E. Di Pierro, P. Dongiovanni